Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has scheduled a board meeting for the 27th of August, 2024, to review and approve its subsidiary companies’ interim financial results for the first half of the year. The announcement indicates the company’s commitment to transparency in its financial performance and strategic developments.
For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.
